Haitao Gu
Shanghai, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Targeting OAS3 for reversing M2d infiltration and restoring anti-tumor immunity in pancreatic cancer.
Journal: Cancer immunology, immunotherapy : CII
Published: September 04, 2024
Exosomal ACADM sensitizes gemcitabine-resistance through modulating fatty acid metabolism and ferroptosis in pancreatic cancer.
Journal: BMC cancer
Published: February 13, 2023
Molecular characteristics, clinical significance, and immune landscape of extracellular matrix remodeling-associated genes in colorectal cancer.
Journal: Frontiers in oncology
Published: November 27, 2022
Deubiquitinase UCHL5 stabilizes ELK3 to potentiate cancer stemness and tumor progression in pancreatic adenocarcinoma (PAAD).
Journal: Experimental cell research
Published: July 05, 2022
Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips.
Journal: iScience
Published: April 29, 2022
NLRP3 activation in tumor-associated macrophages enhances lung metastasis of pancreatic ductal adenocarcinoma.
Journal: Translational lung cancer research
Published: March 14, 2022
Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma.
Journal: Annals of translational medicine
Published: December 29, 2021
CCL2 produced by pancreatic ductal adenocarcinoma is essential for the accumulation and activation of monocytic myeloid-derived suppressor cells.
Journal: Immunity, inflammation and disease
Published: July 13, 2021
Last Updated: 09/26/2026